| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |